HTML<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Intramural Biliary Glands in Liver Transplantation - Enhanced</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;500;700;900&display=swap" rel="stylesheet">
    <style>
        body {
            font-family: 'Roboto', sans-serif;
            background-color: #003F5C; /* Deep Blue */
        }
      .chart-container {
            position: relative;
            width: 100%;
            max-width: 500px;
            margin-left: auto;
            margin-right: auto;
            height: 300px; /* Adjusted for better visibility */
            max-height: 400px;
        }
        @media (min-width: 768px) {
          .chart-container {
                height: 350px;
            }
        }
      .flowchart-node {
            border: 2px solid #7A5195; /* Purple */
            background-color: #f8fafc; /* Light gray */
        }
      .flowchart-arrow {
            color: #7A5195; /* Purple */
            font-weight: bold;
        }
      .details-button {
            background-color: #FFA600; /* Yellow/Orange */
            color: white;
            padding: 0.25rem 0.75rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
            transition: background-color 0.3s;
        }
      .details-button:hover {
            background-color: #FF764A; /* Orange */
        }
      .details-content {
            background-color: #f0f9ff; /* Very light blue */
            border-left: 4px solid #7A5195; /* Purple */
            padding: 1rem;
            margin-top: 1rem;
            border-radius: 0.25rem;
        }
      .details-content h4 {
            color: #003F5C; /* Deep Blue */
            font-weight: 600;
            margin-bottom: 0.5rem;
        }
      .details-content p,.details-content ul {
            font-size: 0.875rem; /* 14px */
            color: #334155; /* Slate 700 */
            margin-bottom: 0.5rem;
        }
      .details-content ul {
            list-style-type: disc;
            padding-left: 1.25rem;
        }
      .sources-section h3 { /* Retained for potential future use, though current h2 is primary */
            color: #003F5C; /* Deep Blue */
            font-weight: 600;
            margin-bottom: 0.5rem;
        }
      .ama-sources-list {
            list-style-type: decimal; /* Standard 1, 2, 3 numbering */
            padding-left: 20px; /* Standard indent for ordered lists */
            margin-top: 1rem;
        }
      .ama-sources-list li {
            margin-bottom: 0.75rem; /* Increased spacing for readability */
            padding-left: 5px; /* Space after the number */
            font-size: 0.875rem;
            color: #334155;
        }
      .ama-sources-list.cite-key {
            font-weight: bold;
            color: #7A5195; /* Purple */
            margin-right: 0.4em;
        }
    </style>
</head>
<body class="text-gray-800">

    <div class="container mx-auto px-4 py-8 sm:px-6 lg:px-8">

        <header class="text-center mb-12">
            <h1 class="text-4xl md:text-5xl font-bold text-white mb-2">The Unseen Battle</h1>
            <p class="text-xl md:text-2xl text-gray-300">Intramural Biliary Glands in Liver Transplantation</p>
        </header>

        <main class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-8">

            <section class="lg:col-span-3 bg-white rounded-lg shadow-xl p-6">
                <div class="flex justify-between items-center mb-3">
                    <h2 class="text-2xl font-bold text-[#003F5C]">Introduction: The Critical Resilience Unit</h2>
                    <button onclick="toggleDetails('introDetails')" class="details-button">Learn More</button>
                </div>
                <p class="mb-4">Within the bile duct wall lie microscopic intramural peribiliary glands (PBGs), essential for biliary health. They provide protective mucus and house biliary tree stem cells (BTSCs), vital for regeneration. Their sole reliance on the arterial peribiliary vascular plexus (PVP) makes them extremely vulnerable in transplantation.</p>
                <div id="introDetails" class="hidden details-content">
                    <h4>Anatomy and Physiology of PBGs:</h4>
                    <p>PBGs are simple tubular structures rich in mucin, sparsely distributed within the bile duct wall.[1] They are crucial for secreting mucins that protect the biliary epithelium and play a role in local immunity.[1] Critically, PBGs serve as a niche for BTSCs, which can proliferate and differentiate to regenerate damaged biliary epithelium.[2, 3, 4, 5]</p>
                    <h4>The Peribiliary Vascular Plexus (PVP):</h4>
                    <p>The PVP is a delicate network of small blood vessels from the hepatic artery, providing the sole arterial blood supply to PBGs.[3, 6] Unlike hepatocytes (dual supply from hepatic artery and portal vein), PBGs' singular arterial dependence makes them highly susceptible to ischemic insults common in liver transplantation.[6]</p>
                    <h4>Significance in Transplantation:</h4>
                    <p>PBG integrity is paramount for allograft health. Their compromise impairs not only routine protection and immunity but also the crucial regenerative response to injuries like ischemia-reperfusion or rejection, leading to a compounded vulnerability.[3, 4]</p>
                </div>
                <div class="flex flex-col md:flex-row items-center justify-center p-4 rounded-lg bg-slate-50 mt-4">
                     <div class="text-center md:text-left md:w-2/3">
                        <h3 class="text-xl font-semibold text-[#7A5195] mb-2">Anatomy of Vulnerability</h3>
                        <p class="text-sm">The PBG/PVP complex acts as a single unit. A blow to the arterial supply (PVP) is a direct hit on the glands (PBGs), crippling the bile duct's ability to defend and repair itself.</p>
                    </div>
                    <div class="w-full md:w-1/3 mt-4 md:mt-0 flex justify-center">
                        <div class="w-48 h-48 border-4 border-[#003F5C] rounded-lg p-2 relative flex items-center justify-center text-center text-xs">
                            <div class="absolute -top-4 bg-white px-2 font-bold">Bile Duct Wall</div>
                            <div class="font-semibold text-[#003F5C]">
                                <div class="mb-2">Gland (PBG)</div>
                                <div class="text-2xl">↓</div>
                                <div class="text-red-500 font-bold">Sole Arterial Blood Supply</div>
                                <div class="text-2xl">↓</div>
                                <div>Vessel (PVP)</div>
                            </div>
                        </div>
                    </div>
                </div>
            </section>
            
            <section class="bg-white rounded-lg shadow-xl p-6">
                <div class="flex justify-between items-center mb-3">
                    <h2 class="text-2xl font-bold text-[#003F5C]">The Initial Assault: Ischemia-Reperfusion Injury (IRI)</h2>
                    <button onclick="toggleDetails('iriDetails')" class="details-button">Learn More</button>
                </div>
                <p class="mb-4">Ischemia-Reperfusion Injury (IRI) is the first major hurdle, causing direct damage to PBGs and their blood supply. Livers from Donors after Circulatory Death (DCD) suffer more severe ischemic damage, leading to a higher incidence of biliary complications.</p>
                <div id="iriDetails" class="hidden details-content">
                    <h4>Pathophysiology of IRI:</h4>
                    <p>IRI results from hypoxia during organ procurement/preservation, followed by reoxygenation that triggers reactive oxygen species (ROS), inflammation, and microcirculatory disturbances.[7, 8, 9] The biliary epithelium is highly vulnerable.[6, 7, 10] DCD livers, experiencing prolonged ischemia, show more PBG damage and are prone to non-anastomotic strictures (NAS).[5, 8, 9, 11]</p>
                    <h4>Histopathological Changes:</h4>
                    <p>IRI causes PBG epithelial disruption, pyknotic nuclei, and distorted morphology.[5] The PVP shows reduced density, endothelial apoptosis, subintimal edema, and arteriolonecrosis.[3, 5, 12]</p>
                    <h4>Molecular Responses & The "Double-Edged Sword":</h4>
                    <p>PBGs upregulate HIF-1α and VEGF-A, attempting repair.[4, 5] However, if the microenvironment is severely compromised (e.g., persistent hypoxia), this proliferative drive might become dysregulated, contributing to fibrosis rather than effective re-epithelialization.[3, 4, 5, 13]</p>
                    <h4>Functional Consequences:</h4>
                    <p>IRI impairs PBG regenerative capacity, leading to reduced PBG mass and increased apoptosis in grafts developing NAS.[3] Pre-transplant injury to deep PBGs (>50% loss) strongly predicts post-transplant NAS.[7]</p>
                </div>
                <div class="chart-container mt-4">
                    <canvas id="iriChart"></canvas>
                </div>
                 <p class="text-center text-sm mt-4 text-gray-600">Illustrates the relative risk of severe PBG damage and subsequent non-anastomotic strictures (NAS) based on donor type. Severe IRI in DCD grafts critically impairs PBG regenerative capacity.</p>
            </section>
            
            <section class="bg-white rounded-lg shadow-xl p-6">
                 <div class="flex justify-between items-center mb-3">
                    <h2 class="text-2xl font-bold text-[#003F5C]">The Immune Onslaught: Allograft Rejection</h2>
                    <button onclick="toggleDetails('rejectionDetails')" class="details-button">Learn More</button>
                </div>
                <p class="mb-4">The recipient's immune system can attack the allograft, with the biliary system being a primary target. Both acute and chronic rejection damage PBGs and compromise their function.</p>
                <div id="rejectionDetails" class="hidden details-content">
                    <h4>Acute Cellular Rejection (ACR):</h4>
                    <p>Primarily a T-lymphocyte mediated response targeting interlobular bile ducts and likely PBGs.[2, 14] Histology shows lymphocytic infiltrates and ductitis (epithelial damage).[14] PBGs within affected ducts likely suffer similar injury, impairing mucin secretion and regeneration.</p>
                    <h4>Chronic (Ductopenic) Rejection:</h4>
                    <p>An insidious, often irreversible injury evolving from persistent ACR.[15, 16] Key features are bile duct loss (ductopenia) and obliterative arteriopathy (foam cell lesions compromising blood supply).[15, 16] Ductopenia implies PBG loss, either from direct immune attack or secondary ischemia.[2, 15] Periductal fibrosis is common.[2, 13]</p>
                    <h4>Diagnostic Aids & Implications:</h4>
                    <p>CK7 immunohistochemistry confirms duct loss and reveals cholangiolar metaplasia.[15] PBG destruction in chronic rejection abrogates the BTSC niche, leading to irreversible graft damage.[17] Distinguishing direct immune vs. ischemic PBG damage can be challenging in advanced stages.[2, 14, 15, 16]</p>
                </div>
                <div class="chart-container mt-4">
                    <canvas id="rejectionChart"></canvas>
                </div>
                 <p class="text-center text-sm mt-4 text-gray-600">Acute rejection involves direct inflammatory attack. Chronic rejection leads to irreversible loss of bile ducts (ductopenia) and associated PBGs, often due to vascular damage.</p>
            </section>

            <section class="bg-white rounded-lg shadow-xl p-6 flex flex-col">
                <div class="flex justify-between items-center mb-3">
                    <h2 class="text-2xl font-bold text-[#003F5C]">The Opportunistic Invader: CMV Infection</h2>
                    <button onclick="toggleDetails('cmvDetails')" class="details-button">Learn More</button>
                </div>
                <p class="mb-4">Cytomegalovirus (CMV) is a major threat. It preferentially infects actively dividing cells. When PBGs proliferate to repair prior damage (from IRI or rejection), they become "fertile soil" for CMV, which then destroys these regenerative units.</p>
                 <div id="cmvDetails" class="hidden details-content">
                    <h4>CMV Cholangiopathy:</h4>
                    <p>CMV is the most frequent opportunistic infection post-LT, associated with biliary strictures (anastomotic and NAS).[18, 19, 20, 21, 22] CMV DNA is often more detectable in bile than blood in patients with biliary issues, suggesting localized biliary tract activity.[20]</p>
                    <h4>Mechanisms of Damage:</h4>
                    <p>CMV causes direct viral cytopathic effects (e.g., "owl's eye" inclusions in biliary/PBG epithelium) [19, 23] and indirect damage via immunomodulation, potentially worsening alloimmune responses or creating a pro-inflammatory environment.[24, 25] "Activated" or proliferating PBGs are particularly susceptible targets for CMV replication.[21]</p>
                    <h4>Histopathology & Diagnosis:</h4>
                    <p>Classic CMV infection shows cytomegalic cells with large intranuclear inclusions.[19] PBG glandular epithelium can show these changes.[23] IHC for CMV antigens or ISH/RNAscope for viral nucleic acids confirm infection.[18, 20, 26]</p>
                    <h4>Clinical Impact:</h4>
                    <p>CMV antigenemia is strongly associated with adverse biliary outcomes.[18] Occult CMV in the biliary tract (detectable in bile, not blood) may drive biliary stenosis and graft failure.[20] PBGs could be significant sites of CMV replication and shedding into bile.[1, 20]</p>
                </div>
                <div class="flex-grow flex items-center justify-center space-x-2 sm:space-x-4 p-4 bg-slate-50 rounded-lg mt-4">
                    <div class="text-center">
                        <div class="text-3xl sm:text-5xl">🌱</div>
                        <p class="font-semibold text-xs sm:text-sm">Activated PBG (Repairing)</p>
                    </div>
                    <div class="text-2xl sm:text-4xl font-bold text-red-500">→</div>
                     <div class="text-center">
                        <div class="text-3xl sm:text-5xl">🦠</div>
                        <p class="font-semibold text-xs sm:text-sm">CMV Infection</p>
                    </div>
                    <div class="text-2xl sm:text-4xl font-bold text-red-500">→</div>
                    <div class="text-center">
                        <div class="text-3xl sm:text-5xl">💥</div>
                        <p class="font-semibold text-xs sm:text-sm">Regenerative Failure</p>
                    </div>
                </div>
                 <p class="text-sm mt-4 text-gray-600">This synergistic pathology, where healing attempts increase vulnerability, highlights how multiple insults can compound severe biliary damage.</p>
            </section>

            <section class="md:col-span-2 lg:col-span-3 bg-white rounded-lg shadow-xl p-6">
                <div class="flex justify-between items-center mb-3">
                    <h2 class="text-2xl font-bold text-[#003F5C]">Pathway to Failure: Non-Anastomotic Stricture (NAS) Formation</h2>
                    <button onclick="toggleDetails('nasDetails')" class="details-button">Learn More</button>
                </div>
                <p class="mb-4">Non-anastomotic strictures (NAS) are a dreaded complication from a cascade of events, rooted in failed PBG-mediated regeneration. Unrepaired biliary epithelium leads to a vicious cycle of bile salt toxicity and fibrosis, causing scarring and duct narrowing.</p>
                <div id="nasDetails" class="hidden details-content">
                    <h4>Role of PBG/PVP Damage in NAS:</h4>
                    <p>Damage to PBGs and the PVP is critical in NAS development.[3, 5, 7, 8, 9] NAS are often multiple strictures proximal to the anastomosis, common after IRI, especially in DCD livers.[5, 8, 9, 11, 27, 28]</p>
                    <h4>Mechanisms of Failed Regeneration:</h4>
                    <ul>
                        <li><strong>Reduced PBG Viability:</strong> Livers developing NAS show reduced PBG mass, decreased PBG cell proliferation, and increased apoptosis.[3]</li>
                        <li><strong>Compromised Microenvironment:</strong> PVP damage leads to persistent local hypoxia, hampering regeneration.[8, 9]</li>
                        <li><strong>Bile Salt Toxicity & Dysregulated Healing:</strong> Delayed repair exposes denuded areas to cytotoxic bile salts, aggravating injury and promoting a fibrotic (rather than regenerative) wound-healing response.[9]</li>
                        <li><strong>Exhaustion/Dysregulation:</strong> Initial PBG activation (e.g., ↑VEGF-A [5]) may become overwhelmed by chronic insults (hypoxia, inflammation, bile toxicity), leading to senescence or a shift towards pro-fibrotic signaling.[3, 4, 8, 9]</li>
                    </ul>
                    <h4>Predictors and Contributing Factors:</h4>
                    <p>Injury to deep PBGs pre-transplant is a strong NAS predictor.[7] The higher NAS incidence in DCD livers underscores the PBG/PVP complex's vulnerability to severe warm ischemia.[5, 8, 9] Immunological insults (rejection, ABO incompatibility) can also contribute to PBG damage and NAS.[8, 9, 11, 27]</p>
                </div>
                <div class="flex flex-col items-center space-y-4 p-4 mt-4">
                    <div class="flowchart-node w-full md:w-3/4 text-center p-3 rounded-lg shadow-md">
                        <h3 class="font-bold">Initial Insult</h3>
                        <p class="text-sm">Ischemia-Reperfusion, Rejection, or Infection</p>
                    </div>
                    <div class="text-3xl flowchart-arrow">↓</div>
                    <div class="flowchart-node w-full md:w-3/4 text-center p-3 rounded-lg shadow-md">
                        <h3 class="font-bold">PBG / PVP Damage</h3>
                        <p class="text-sm">Direct gland injury & compromised blood supply</p>
                    </div>
                    <div class="text-3xl flowchart-arrow">↓</div>
                    <div class="flowchart-node w-full md:w-3/4 text-center p-3 rounded-lg shadow-md">
                        <h3 class="font-bold text-red-600">Failed/Dysregulated Regeneration</h3>
                        <p class="text-sm">PBG stem cells cannot repair the denuded bile duct lining</p>
                    </div>
                    <div class="text-3xl flowchart-arrow">↓</div>
                    <div class="flowchart-node w-full md:w-3/4 text-center p-3 rounded-lg shadow-md">
                        <h3 class="font-bold">Ongoing Injury & Fibrosis</h3>
                        <p class="text-sm">Exposure to toxic bile salts promotes a chronic wound-healing response leading to scarring</p>
                    </div>
                    <div class="text-3xl flowchart-arrow">↓</div>
                    <div class="flowchart-node bg- text-white w-full md:w-3/4 text-center p-3 rounded-lg shadow-md">
                        <h3 class="font-bold">Non-Anastomotic Stricture (NAS)</h3>
                        <p class="text-sm">Permanent scarring and narrowing of the bile duct</p>
                    </div>
                </div>
            </section>
            
            <section class="md:col-span-2 lg:col-span-3 bg-white rounded-lg shadow-xl p-6 overflow-x-auto">
                <div class="flex justify-between items-center mb-3">
                    <h2 class="text-2xl font-bold text-[#003F5C]">Diagnostic Summary: PBG Alterations</h2>
                    <button onclick="toggleDetails('diagnosticDetails')" class="details-button">Learn More</button>
                </div>
                 <p class="mb-4">Distinguishing causes of biliary injury is challenging. This table summarizes key histopathological features affecting the PBG/PVP unit. Features often overlap, requiring clinical correlation.</p>
                <div id="diagnosticDetails" class="hidden details-content">
                    <h4>Challenges in Diagnosis:</h4>
                    <p>A significant diagnostic challenge in post-transplant liver biopsies is dissecting the relative contributions of co-existing pathologies (e.g., IRI, ACR, chronic rejection, CMV). PBG alterations (atrophy, inflammation) can be non-specific. Therefore, PBG findings must be integrated with other histological features (type/location of inflammation, vascular changes, viral inclusions) and the broader clinical context.[14, 15]</p>
                    <h4>Immunohistochemistry (IHC) Utility:</h4>
                    <p>CK7 highlights biliary epithelium (including PBGs) and assesses ductopenia.[15] For CMV, IHC for viral antigens or ISH/RNAscope for nucleic acids are key.[18, 20] Research markers for PBG stem cells (Sox9, Nanog, EpCAM) exist but are not routine.[4]</p>
                </div>
                <div class="w-full mt-4">
                    <table class="w-full text-sm text-left border-collapse">
                        <thead>
                            <tr class="bg-[#003F5C] text-white">
                                <th class="p-3 border">Pathological Condition</th>
                                <th class="p-3 border">Key PBG Changes</th>
                                <th class="p-3 border">Key PVP Changes</th>
                                <th class="p-3 border">Primary Injury Mechanism</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr class="border-b hover:bg-slate-50">
                                <td class="p-3 border font-semibold">Ischemia-Reperfusion Injury</td>
                                <td class="p-3 border">Epithelial disruption, pyknotic nuclei, necrosis, reduced mass [3, 5]</td>
                                <td class="p-3 border">Endothelial cell apoptosis, reduced density, subintimal edema, arteriolonecrosis [3, 5, 12]</td>
                                <td class="p-3 border">Hypoxia/Reoxygenation, Oxidative Stress</td>
                            </tr>
                            <tr class="border-b hover:bg-slate-50">
                                <td class="p-3 border font-semibold">Acute Cellular Rejection</td>
                                <td class="p-3 border">Lymphocytic infiltrates, epithelial damage (vacuolization, eosinophilia) [14]</td>
                                <td class="p-3 border">Endotheliitis (lymphocytic infiltration of PVP vessels) [14]</td>
                                <td class="p-3 border">T-cell Mediated Cytotoxicity</td>
                            </tr>
                            <tr class="border-b hover:bg-slate-50">
                                <td class="p-3 border font-semibold">Chronic (Ductopenic) Rejection</td>
                                <td class="p-3 border">Atrophy, loss/absence of glands, surrounding fibrosis [2, 15]</td>
                                <td class="p-3 border">Obliterative arteriopathy (foam cell lesions, intimal thickening) [15, 16]</td>
                                <td class="p-3 border">Sustained Immune Attack & Chronic Ischemia</td>
                            </tr>
                            <tr class="border-b hover:bg-slate-50">
                                <td class="p-3 border font-semibold">CMV Cholangiopathy</td>
                                <td class="p-3 border">Cytomegalic cells with "owl's eye" inclusions, inflammation, necrosis [18, 19, 23]</td>
                                <td class="p-3 border">Inflammation may be present; specific changes not well-defined for PVP alone.</td>
                                <td class="p-3 border">Viral Cytopathic Effect, Immune Modulation</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
            </section>

            <section class="lg:col-span-3 bg-white rounded-lg shadow-xl p-6 sources-section">
                <h2 class="text-2xl font-bold text-[#003F5C] mb-4">Sources</h2>
                <p class="mb-4 text-sm text-gray-700">The numbered items below correspond to reference indicators (e.g., [1, 2]) used in the "Learn More" sections. These indicators link to topics from the comprehensive research report from which this infographic is derived, referencing citations within that main report.</p>
                <ol class="ama-sources-list">
                    <li><span class="cite-key">[1, 2]</span> Anatomical/histological characteristics of PBGs; PBGs as a niche for Biliary Tree Stem/Progenitor Cells (BTSCs); PBG involvement in ductopenic rejection.</li>
                    <li><span class="cite-key">[3, 6]</span> The Peribiliary Vascular Plexus (PVP), its hepatic artery dependence, and vulnerability to ischemia; PBG damage in IRI and NAS.</li>
                    <li><span class="cite-key">[4, 5]</span> PBG stem cell function, activation in response to injury (proliferation, VEGF-A, HIF-1α); PBG damage in DCD livers and NAS.</li>
                    <li><span class="cite-key">[7, 8, 9]</span> Ischemia-Reperfusion Injury (IRI) as a principal cause of biliary complications; PBG/PVP damage; link to Non-Anastomotic Strictures (NAS), especially in DCD livers; bile salt toxicity.</li>
                    <li><span class="cite-key">[10]</span> Biliary epithelium vulnerability to ischemia; BDI score limitations.</li>
                    <li><span class="cite-key">[11]</span> Higher NAS incidence in DCD livers; multifactorial NAS pathogenesis including IRI and immune factors.</li>
                    <li><span class="cite-key">[12]</span> Histological manifestations of PVP injury in IRI (subintimal edema, arteriolonecrosis, hemorrhage).</li>
                    <li><span class="cite-key">[13]</span> Periductal fibrosis in chronic rejection; dysregulated PBG regeneration contributing to fibrosis.</li>
                    <li><span class="cite-key">[14]</span> Acute Cellular Rejection (ACR) mechanisms, histopathology (lymphocytic infiltrates, ductitis); diagnostic challenges with co-existing pathologies.</li>
                    <li><span class="cite-key">[15, 16]</span> Chronic (Ductopenic) Rejection pathogenesis, histopathology (ductopenia, obliterative arteriopathy); CK7 utility; evolution from ACR.</li>
                    <li><span class="cite-key">[17]</span> Implications of PBG stem cell loss in chronic rejection for graft survival.</li>
                    <li><span class="cite-key">[27, 29]</span> Biliary strictures (including NAS) as major post-transplant complications; multifactorial etiology of NAS.</li>
                    <li><span class="cite-key">[28]</span> Characteristics of NAS (proximal, multiple).</li>
                    <li><span class="cite-key">[18, 19, 20]</span> CMV cholangiopathy, association with biliary complications; CMV detection (bile vs. blood, IHC/ISH/RNAscope); direct viral cytopathic effects.</li>
                    <li><span class="cite-key">[21]</span> CMV predilection for activated/proliferating tissues (e.g., regenerating PBGs); link to chronic rejection.</li>
                    <li><span class="cite-key">[22]</span> CMV as a risk factor for anastomotic biliary strictures.</li>
                    <li><span class="cite-key">[24, 25]</span> Indirect mechanisms of CMV damage (immunomodulation).</li>
                    <li><span class="cite-key">[23]</span> CMV cytopathic changes (amphophilic changes) in PBG glandular epithelium.</li>
                    <li><span class="cite-key">[26]</span> Confirmation of CMV in tissue via IHC/ISH/RNAscope.</li>
                </ol>
            </section>

             <section class="lg:col-span-3 text-center mt-8">
                <p class="text-gray-300 text-sm">This infographic synthesizes findings from clinical research on liver allograft pathology for educational purposes. Visualizations are based on principles and relative data from source literature. No SVG or Mermaid JS used.</p>
            </section>
        </main>
    </div>

    <script>
        function toggleDetails(elementId) {
            const element = document.getElementById(elementId);
            if (element) {
                element.classList.toggle('hidden');
            }
        }

        const wrapLabel = (label, maxLength = 16) => {
            if (typeof label!== 'string') return label;
            if (label.length <= maxLength) return label;

            const words = label.split(' ');
            const lines =;
            let currentLine = '';

            words.forEach(word => {
                if ((currentLine + ' ' + word).trim().length > maxLength) {
                    lines.push(currentLine.trim());
                    currentLine = word;
                } else {
                    currentLine = (currentLine + ' ' + word).trim();
                }
            });
            if (currentLine) {
                lines.push(currentLine.trim());
            }
            return lines;
        };

        const tooltipTitleCallback = (tooltipItems) => {
            const item = tooltipItems;
            let label = item.chart.data.labels[item.dataIndex];
            if (Array.isArray(label)) {
              return label.join(' ');
            }
            return label;
        };
        
        const brilliantBluesPalette = {
            darkBlue: '#003F5C',
            purpleBlue: '#374C80',
            purple: '#7A5195',
            magenta: '#BC5090',
            pink: '#EF5675',
            orange: '#FF764A',
            yellow: '#FFA600'
        };

        const commonChartOptions = {
            responsive: true,
            maintainAspectRatio: false,
            plugins: {
                legend: {
                    labels: {
                        color: '#4b5563' // Tailwind gray-600
                    }
                },
                tooltip: {
                    callbacks: {
                        title: tooltipTitleCallback
                    }
                }
            },
            animation: {
                duration: 500 // Smoother animation
            }
        };

        const iriCtx = document.getElementById('iriChart').getContext('2d');
        new Chart(iriCtx, {
            type: 'doughnut',
            data: {
                labels:,
                datasets:, 
                    backgroundColor:,
                    borderColor: '#fff',
                    borderWidth: 2,
                    hoverOffset: 4
                }]
            },
            options: {
              ...commonChartOptions,
                plugins: {
                  ...commonChartOptions.plugins,
                    title: {
                        display: true,
                        text: 'Relative Risk of Severe PBG Damage by Donor Type',
                        color: '#1f2937', // Tailwind gray-800
                        font: { size: 14, weight: '500' }
                    }
                },
                cutout: '50%' 
            }
        });

        const rejectionCtx = document.getElementById('rejectionChart').getContext('2d');
        const rejectionLabels =;
        new Chart(rejectionCtx, {
            type: 'bar',
            data: {
                labels: rejectionLabels.map(label => wrapLabel(label)),
                datasets:, 
                    backgroundColor: brilliantBluesPalette.orange,
                    borderColor: brilliantBluesPalette.orange,
                    borderWidth: 1,
                    borderRadius: 4
                }, {
                    label: 'Chronic (Ductopenic) Rejection',
                    data: [3, 9, 8, 7], 
                    backgroundColor: brilliantBluesPalette.magenta,
                    borderColor: brilliantBluesPalette.magenta,
                    borderWidth: 1,
                    borderRadius: 4
                }]
            },
            options: {
              ...commonChartOptions,
                indexAxis: 'y',
                scales: {
                    x: {
                        beginAtZero: true,
                        max: 10,
                        title: { display: true, text: 'Relative Severity/Prevalence (0-10)', color: '#4b5563', font: {weight: '500'} },
                        grid: { color: '#e5e7eb' }, // Tailwind gray-200
                        ticks: { color: '#4b5563' }
                    },
                    y: {
                        grid: { display: false },
                        ticks: { color: '#4b5563' }
                    }
                },
                 plugins: {
                   ...commonChartOptions.plugins,
                    title: {
                        display: true,
                        text: 'Hallmark Features of Rejection Types',
                        color: '#1f2937',
                        font: { size: 14, weight: '500' }
                    }
                }
            }
        });

    </script>
</body>
</html>
